Citation: | XIA Qisheng, DENG Tingting, XU Yaping, LIU Honglin, LIU Haoyuan. Inhibitory Effect of Loropetalum Chinense on Proliferation of Lung Adenocarcinoma A549 Cells[J]. Cancer Research on Prevention and Treatment, 2022, 49(3): 182-186. DOI: 10.3971/j.issn.1000-8578.2022.21.0708 |
To investigate the effects of Loropetalum chinense extracts on the proliferation of lung adenocarcinoma A549 cells cultured in vitro.
CCK-8 assay was performed to evaluate the effect of Loropetalum chinense extracts on the proliferation of A549 cells, and the clonal growth ability of A549 cells was determined by clone formation assay. Flow cytometry Annexin V-APC/PI double staining was used to measure the apoptosis of A549 cells. Western blot was used to measure the expressions of apoptosis-related proteins Bax, Fas, Bcl-2 Caspase3 and cleaved-Caspase 3.
Loropetalum chinense extracts significantly inhibited the proliferation and colony formation of A549 cells in a time- and dose-dependent manner. The viability of A549 cells decreased by 50% after 48h treatment of 0.5mg/ml extracts, and 100% inhibition of colony formation rate achieved when the cells were treated with 40μg/ml extracts for 14 days. When A549 cells were treated with Loropetalum chinense extracts for 24h, apoptotic rates increased in a dose-dependent manner. Compared with the control group, the protein levels of Fas, Bax, Caspase3 and cleaved-Caspase3 were up-regulated, while Bcl-2 was down-regulated.
Loropetalum chinense extracts inhibit the growth of human lung adenocarcinoma cells in vitro, and the mechanisms may be related to the activation of mitochondrial and death receptor apoptosis pathway.
Competing interests: The authors declare that they have no competing interests.
[1] |
王刚, 刘劲松, 李红艳, 等. 檵木化学成分研究[J]. 天然产物研究与开发, 2011, 23(2): 267-269. https://www.cnki.com.cn/Article/CJFDTOTAL-TRCW201102017.htm
Wang G, Liu JS, Li HY, et al. Chemical constituents of Loropetalum chinense[J]. Tian Ran Chan Wu Yan Jiu Yu Kai Fa, 2011, 23(2): 267-269. https://www.cnki.com.cn/Article/CJFDTOTAL-TRCW201102017.htm
|
[2] |
肖珑, 岳勇志, 陈靖宇, 等. 檵木药用活性成分及药理作用研究进展[J]. 湖南农业科学, 2017, (6): 119-121, 126. https://www.cnki.com.cn/Article/CJFDTOTAL-HNNK201706034.htm
Xiao L, Yue YZ, Chen JY, et al. Research progress of active pharmaceutical ingredients and pharmacological action of Loropetalum chinense var. rubrum[J]. Hunan Nong Ye Ke Xue, 2017, (6): 119-121, 126. https://www.cnki.com.cn/Article/CJFDTOTAL-HNNK201706034.htm
|
[3] |
潘晓军, 吕圭源, 陈素红, 等. 白花檵木花黄酮提取及其抗氧化活性的研究[J]. 中国医药指南, 2012, 10(26): 75-76. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK201226041.htm
Pan XJ, Lyu GY, Chen SH, et al. The extraction of flavonoids from Loropetalum chinense and its' antioxidant activity[J]. Zhongguo Yi Yao Zhi Nan, 2012, 10(26): 75-76. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXK201226041.htm
|
[4] |
连泽勤, 高健, 李晓滨, 等. 白花檵木促大鼠皮肤伤口愈合物质基础初步研究[J]. 中国中药杂志, 2013, 38(20): 3566-3570. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201320033.htm
Lian ZQ, Gao J, Li XB, et al. Primary study of skin wound healing in rays for Loropetalum chinense[J]. Zhongguo Zhong Yao Za Zhi, 2013, 38(20): 3566-3570. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201320033.htm
|
[5] |
张季林, 徐彭, 董德刚, 等. 白花檵木有效部位治疗糖尿病皮肤溃疡机制研究[J]. 中草药, 2017, 48(14): 2907-2911. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201714017.htm
Zhang JL, Xu P, Dong DG, et al. Mechanism of loropetalum chinensis in treatment of diabetic skin ulcer[J]. Zhong Cao Yao, 2017, 48(14): 2907-2911. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201714017.htm
|
[6] |
Crawford JM, Tang GL, Herzon SB. Natural Products: An Era of Discovery in Organic Chemistry[J]. J Org Chem, 2021, 86(16): 10943-10945. doi: 10.1021/acs.joc.1c01753
|
[7] |
Dias AS, Helguero L, Almeida CR, et al. Natural Compounds as Metabolic Modulators of the Tumor Microenvironment[J]. Molecules, 2021, 26(12): 3494. doi: 10.3390/molecules26123494
|
[8] |
涂越, 刘建平, 郭雄昌, 等. 白花檵木中主要活性成分及其治疗慢性难愈性创面的展望[J]. 江西科学, 2021, 39(4): 585-592. https://www.cnki.com.cn/Article/CJFDTOTAL-JSKX202104003.htm
Tu Y, Liu JP, Guo XC, et al. Phytochemical components and bioactivities of Loropetalum cinense: research advances[J]. Jiangxi Ke Xue, 2021, 39(4): 585-592. https://www.cnki.com.cn/Article/CJFDTOTAL-JSKX202104003.htm
|
[9] |
Hafezi S, Rahmani M. Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives[J]. Cancers (Basel), 2021, 13(6): 1292. doi: 10.3390/cancers13061292
|
[10] |
Zhang Y, Yang X, Ge X, et al. Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice[J]. Biomed Pharmacother, 2019, 109: 726-733. doi: 10.1016/j.biopha.2018.10.161
|
[11] |
钟大仓, 陈超, 李桐, 等. 胡椒碱诱导人胰腺癌PANC-1细胞凋亡的Caspase 3/Bax/Bcl-2信号通路机制研究[J]. 中国现代应用药学, 2020, 37(14): 1687-1691. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYD202014004.htm
Zhong DC, Chen C, Li T, et al. Study on the caspase 3/bax/bcl-2 signal pathway mechanism of induction apoptosis effect of piperine in human pancreatic cancer PANC-1 cell[J]. Zhongguo Xian Dai Ying Yong Yao Xue, 2020, 37(14): 1687-1691. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYD202014004.htm
|
[12] |
谷泽慧, 任立群, 李琪, 等. 奥沙利铂通过调控miRNA-7-5p/RAF-1促进胃癌SGC-7901细胞凋亡的研究[J]. 肿瘤防治研究, 2020, 47(3): 175-180. doi: 10.3971/j.issn.1000-8578.2020.19.0695
Gu ZH, Ren LQ, Li Q, et al. Oxaliplatin Promotes Apoptosis of Gastric Cancer Cell Line SGC-7901 by Regulating miRNA-7-5p/RAF-1[J]. Zhong Liu Fang Zhi Yan Jiu, 2020, 47(3): 175-180. doi: 10.3971/j.issn.1000-8578.2020.19.0695
|